Dr. Christina Appenzeller
Medizinische Onkologie und Hämatologie · Dept. I
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Ac-cess
Aug 9, 2022SPECTA is a quality assured platform for collecting clinicopathologically annotated biological material, imaging data, operative images, environmental assessment, questionnaires as well as patient-reported outcomes from cancer patients to support bio...
Clinical Studies - Aug 9, 2022 - Dec 31, 2027
Ongoing
Project leader: Appenzeller Christina
Members: Scherrer Julia, Quinter Janine
International Randomised Controlled Trial for the Treatment of Newly Diagnosed Ewing’s Sarcoma Family of Tumours
Aug 30, 2018The objective of the induction/consolidation chemotherapy randomisation (R1) is to compare the VIDE strategy (VIDE induction and VAI/VAC/BuMel consolidation) with the VDC/IE strategy (compressed VDC/IE induction and IE/VC/Bu-Mel consolidation). The e...
Clinical Studies - Aug 30, 2018 - Aug 14, 2014
Automatically Closed
Project leader: Appenzeller Christina